Imprinting-Mutation Mechanisms in Prader-Willi Syndrome  by Ohta, T. et al.
Am. J. Hum. Genet. 64:397–413, 1999
397
Imprinting-Mutation Mechanisms in Prader-Willi Syndrome
T. Ohta,1 T. A. Gray,1 P. K. Rogan,2 K. Buiting,3 J. M. Gabriel,1 S. Saitoh,4 B. Muralidhar,5
B. Bilienska,6 M. Krajewska-Walasek,6 D. J. Driscoll,7 B. Horsthemke,3 M. G. Butler,5 and
R. D. Nicholls1
1Department of Genetics, Case Western Reserve University School of Medicine, and Center for Human Genetics, University Hospitals of
Cleveland, Cleveland; 2Department of Human Genetics, Allegheny University of the Health Sciences, Pittsburgh; 3Institut fu¨r Humangenetik,
Universita¨tsklinikum Essen, Essen, Germany; 4Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan;
5Department of Pediatrics, Vanderbilt University Medical Center, Nashville; 6Department of Genetics, The Children’s Memorial Health
Institute, Warsaw; and 7R. C. Philips Unit, Division of Genetics, Department of Pediatrics, University of Florida College of Medicine,
Gainesville
Summary
Microdeletions of a region termed the “imprinting cen-
ter” (IC) in chromosome 15q11-q13 have been identified
in several families with Prader-Willi syndrome (PWS) or
Angelman syndrome who show epigenetic inheritance
for this region that is consistent with a mutation in the
imprinting process. The IC controls resetting of parental
imprints in 15q11-q13 during gametogenesis. We have
identified a larger series of cases of familial PWS, in-
cluding one case with a deletion of only 7.5 kb, that
narrows the PWS critical region to !4.3 kb spanning the
SNRPN gene CpG island and exon 1. Identification of
a strong DNase I hypersensitive site, specific for the pa-
ternal allele, and six evolutionarily conserved (human-
mouse) sequences that are potential transcription-factor
binding sites is consistent with this region defining the
SNRPN gene promoter. These findings suggest that pro-
moter elements at SNRPN play a key role in the initiation
of imprint switching during spermatogenesis. We also
identified three patients with sporadic PWS who have
an imprinting mutation (IM) and no detectable mutation
in the IC. An inherited 15q11-q13 mutation or a trans-
factor gene mutation are unlikely; thus, the disease in
these patients may arise from a developmental or sto-
chastic failure to switch the maternal-to-paternal imprint
during parental spermatogenesis. These studies allow a
better understanding of a novel mechanism of human
disease, since the epigenetic effect of an IM in the pa-
rental germ line determines the phenotypic effect in the
patient.
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Introduction
Certain regions of the mammalian genome exhibit gene
expression from only the maternally or the paternally
inherited allele, a process referred to as genomic im-
printing. Imprinted genes are marked differently in the
female and the male germ lines, leading to differences
in somatic expression and function of the two alleles.
Most imprinted genes identified in the mouse and human
genomes lie within large clusters (Reik andMaher 1997;
Nicholls et al. 1998). Each imprinted gene or region
shows several typical features, including monoallelic ex-
pression, differential DNA methylation, and asynchro-
nous DNA replication of the maternal and paternal al-
leles (Nicholls et al. 1998). Despite extensive analysis of
imprinted genes, the molecular mechanisms by which
parental-specific imprints are established in the germ line
and regulated during embryonic and adult development
are still poorly understood.
Prader-Willi syndrome (PWS; MIM 176270) and An-
gelman syndrome (AS; MIM 105830) are distinct de-
velopmental and neurobehavioral syndromes that arise
from abnormal imprinted-gene expression in humans.
Each syndrome occurs at a frequency of ∼1/15,000
births (Clayton-Smith and Pembrey 1992; Cassidy
1997). Approximately 70%–80% of patients with PWS
or AS have a large 4-Mb deletion in the paternal or the
maternal chromosome 15q11-q13 region, respectively
(Nicholls et al. 1998). Both syndromes also result from
uniparental disomy (UPD), which is of maternal origin
in patients with PWS and of paternal origin in patients
with AS. Therefore, PWS results from the loss of a
gene(s) that is expressed only from the paternally in-
herited chromosome, and AS results from the loss of
maternal-only gene expression. A single gene (UBE3A)
that displays regional brain-specific imprinting in hu-
mans and mice is implicated in AS (Malzac et al. 1998;
Nicholls et al. 1998). In contrast, PWS is likely to be a
contiguous-gene syndrome (Nicholls et al. 1998), and,
consistent with this hypothesis, multiple imprinted and
398 Am. J. Hum. Genet. 64:397–413, 1999
Figure 1 PWS domain in proximal chromosome 15q11-q13. The positions of genes and genetic markers (circles), transcription from
paternal (“PAT”) or maternal (“MAT”) alleles, common cytogenetic deletion breakpoints (zigzag lines), and regions involved in PWS, AS, and
the IC are illustrated. A plus sign () indicates presence of expression, and a minus sign () indicates no expression.
paternal-only expressed genes have been identified in
15q11-q13 (fig. 1).
An unusual class of patients with PWS and AS have
a mutation in the imprinting process. These patients have
neither the typical deletion nor UPD, and, although they
have biparental inheritance for chromosome 15 DNA
markers, they show uniparental DNA-methylation
(Glenn et al. 1993; Reis et al. 1994; Sutcliffe et al. 1994;
Buiting et al. 1995) and gene-expression (Saitoh et al.
1996) patterns throughout the 1.5–2.0 Mb imprinted
domain within 15q11-q13 (fig. 1). Accordingly, in pa-
tients with PWS, the paternally inherited chromosome
possesses a maternal imprint and vice versa for cases of
AS. Furthermore, these findings imply that all genes in
the 1.5–2.0-Mb imprinted region are under coordinate
regulation (Saitoh et al. 1996). Definition of the molec-
ular pathogenic mechanism in these patients therefore
should lead to significant insights into the molecular
mechanism of imprinting.
We previously identified inherited microdeletions of
5.5–80 kb in eight families with an AS imprinting mu-
tation (IM) and of 45–200 kb in three families with a
PWS IM, defining an element termed the “imprinting
center” (IC) (Buiting et al. 1995; Saitoh et al. 1996; Ohta
et al. 1999 [in this issue]). On the basis of the inheritance
patterns of these microdeletions and the DNA methyl-
ation and gene-expression imprint pattern on this chro-
mosome, we suggested that the IC controls imprint
switching in the male and female germ line (Buiting et
al. 1995; Dittrich et al. 1996; Saitoh et al. 1996; Nicholls
et al. 1998). IC microdeletions can transmit silently for
multiple generations, but, when the sex of the trans-
mitting individual changes, the mutation blocks the ap-
propriate resetting of the imprint specific for that indi-
vidual’s germ line. Thus, PWS IC mutations block the
normal maternal-to-paternal imprint switch in the male
germ line, and AS IC mutations block the paternal-to-
maternal imprint switch in the female germ line.
To further investigate the IM molecular mechanism
and to define the IC sequence elements that play a role
in the imprint switch, we performed molecular genetic
studies of a significantly larger series of patients with
PWS who have an IM. Two classes of patients with a
PWS IM were identified, deletion and nondeletion. By
means of deletion studies, we narrowed the IC critical
region involved in initiation of the male germ-line switch
to !4.3 kb spanning the promoter of the SNRPN gene.
Therefore, this one gene is intimately involved in the cis
regulation of all imprinted genes over a 1.5–2-Mb do-
main within 15q11-q13, during spermatogenesis.
Subjects and Methods
Clinical Reports
Brief reports for patients with novel molecular find-
ings are presented here, for comparison with typical pa-
tients with a PWS deletion and UPD, who display neo-
natal hypotonia with a failure to thrive, hyperphagia and
severe obesity, mental retardation with learning dis-
abilities, obsessive-compulsive disorder, hypogonadism,
short stature, and small hands and feet (Cassidy 1997).
Clinical and cytogenetic studies of two affected sibs in
each of the families PWS-J and PWS-T have been re-
ported elsewhere (Ishikawa et al. 1996; Teshima et al.
1996).
Patient PWS-14.—PWS-14 is patient 19 in our pre-
vious RFLP analyses (Mascari et al. 1992). At the time
she was last seen, patient PWS-14 was 21 years old and
had many features of PWS, including short stature, small
hands and feet, hypogonadism, truncal obesity (she is
on a 600-cal/d diet), behavior problems that included
tantrums and stealing of food, and dysmorphic features,
including almond-shaped eyes, a narrow bifrontal di-
ameter, and triangular mouth (fig. 2a).
Patient PWS-29.—PWS-29 is patient 28 in our pre-
vious report of RFLP studies (Mascari et al. 1992). At
age 7 years 3 mo (fig. 2b and c), this African American
boy weighed 46.95 kg (197th percentile) and was 118.1
cm tall (5th percentile). His head circumference was 54
cm (80th percentile). Hand length was 14.6 cm (50th
percentile), middle-finger length was 5.4 cm (5th per-
centile), and ear length was 6 cm (75th percentile). His
blood pressure was 110/72 mm Hg. Decreased fetal ac-
tivity was noted by the mother, as compared with a
second pregnancy; otherwise, the pregnancy was nor-
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Figure 2 Clinical photographs of PWS patients. a, PWS-14. This patient has the smallest known PWS deletion (7.5 kb). b and c, PWS-
29. d and e, PWS-B. f, PWS-G. These three patients with an IM have no 15q11-q13 IC microdeletion or detectable mutation. Note the small
hands typical of PWS. g and h, PWS-P sibs. These sibs have a large IC deletion.
mal. He was born at term by vaginal delivery and
weighed 29.23 kg (10th percentile), with a birth length
of 48.3 cm (10th percentile). Hypotonia, cryptorchi-
dism, small penis, weak cry, and poor sucking reflexwere
noted at birth. Feeding difficulties relating to a poor
sucking reflex were present during infancy. He had de-
velopmental delay, particularly gross-motor and speech
delay. Hyperphagia was a recognized problem by age 4
years, and marked obesity developed subsequently. He
has a history of sticky saliva and enamel hypoplasia.
Behavioral problems were noted by age 4 years and in-
cluded stubbornness, temper tantrums, and skin picking.
The family history was unremarkable. The results of
high-resolution chromosome analysis and FISH with the
SNRPN probe were normal.
Patient PWS-B.—PWS-B is a girl, aged 4 years 2 mo,
with features consistent with the diagnosis of PWS (fig.
2d and e). She initially was seen at age 16 mo with a
history of hypotonia during infancy, poor sucking reflex,
developmental/speech delay, and small hands and feet.
She weighed 2.9 kg at birth, which was 2 wk post term.
She was delivered vaginally. Decreased fetal movements
were noted; otherwise, the pregnancy was uncompli-
cated. Levels of organic acids and plasma amino acids
in urine were within the normal ranges, and the results
of a high-resolution chromosome study were normal
(46,XX), including those for FISH analysis with probe
A (D15S11) and probe B (GABRB3) (Oncor). The fam-
ily history was unremarkable, and the patient has an
older sister and a younger brother who are healthy.
At age 20 mo, her height was 74.3 cm (3d percentile),
weight was 9.3 kg (5th percentile), head circumference
was 47 cm (30th percentile), hand length was 8.6 cm,
middle-finger length was 3.6 cm, inner-canthal distance
was 3.2 cm, outer-canthal distance was 5.6 cm, ear
length was 4.6 cm, and foot length was 10.3 cm. At age
4 years 2 mo (fig. 2b), her height was 92.5 cm (5th
percentile), weight was 21.3 kg (95th percentile), head
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circumference was 49.6 cm (40th percentile), middle-
finger length was 4.1 cm (3d percentile), hand length
was 10.4 cm (3d percentile), outer-canthal distance was
6.3 cm (3d percentile), inner-canthal distance was 2.5
cm (10th percentile), and ear length was 5.2 cm (25th
percentile). She was cooperative and had mild devel-
opmental delay. Downturned corners of the mouth, thin
upper lip, short upturned nose, tall-appearing forehead,
small hands and feet, and truncal obesity (triceps and
subscapular skinfold thickness 185th percentile) were
noted. She had sticky saliva, strabismus, almond-shaped
eyes, small chin, dolichocephalic head shape, narrow
bifrontal diameter, clinodactyly of the fifth digits bilat-
erally, and hypotonia. She had a habit of skin picking
and had normal pigmentation. She is described as a
happy, affectionate child, and she has had no history of
hyperphagia.
Patient PWS-G.—When last seen, PWS-G, a 23-year-
old Portuguese woman, was short and morbidly obese
and had the gestalt of PWS (fig. 2f). Her medical history
was significant for neonatal failure to thrive and hy-
potonia. The family history was nonsignificant, with
three older normal sibs; the father is deceased. Height
was 136.8cm (!5th percentile for a 10-year-old), weight
was 110.7 kg (195th percentile), and head circumference
was 54.2 cm (slightly less than the median). There was
mild bitemporal narrowing, with no esotropia or viscous
saliva, and hypernasal speech. Obesity was global, with
predominance at the chest, abdomen, and upper arms
and legs. Breasts were Tanner stage V, with moderate
axillary and pubic hair. She had small hands and feet
(!5th percentile). There were multiple old and new ex-
coriated skin sores. Neurologically, there were no focal
deficits, but there was mild mental retardation and ob-
sessive-compulsive behavior with severe temper tan-
trums and aggressive food-seeking behavior. She has in-
sulin-dependent diabetes, oligomenorrhea, and hypo-
gonadism. Pigmentation was normal for the family back-
ground. The results of high-resolution chromosome
analysis were normal.
Family PWS-P.—Two affected sibs are the only chil-
dren of young, healthy parents of normal intelligence.
Fetal movement during both pregnancies was normal.
For both sibs, results of a high-resolution cytogenetic
study showed normal karyotypes, but FISH studies with
SNRPN and GABRB3 probes revealed the lack of a
signal for the SNRPN probe on one chromosome 15.
Patient 1, a girl, was examined at ages 10 mo and 2, 3,
and 4 years. At each age, she presented with the age-
appropriate spectrum of symptoms usually associated
with PWS. She walked and spoke her first words at age
2 years. At age 4 years (fig. 2g), her weight was 20 kg
(97th percentile), height was 97 cm (10–25 percentile),
and head circumference was 50 cm (50th percentile).
She was found to have a high forehead with a narrow
bifrontal diameter and frontal upsweep of hair, almond-
shaped palpebral fissures, convergent squint, down-
turned corners of the mouth, puffy and delicate hands
with slightly tapering fingers, and hypoplasia of the labia
minora and clitoris. She was judged to be mildly re-
tarded. She has blue eyes and blond hair, as do her par-
ents, and her skin pigmentation is normal.
Patient 2, a boy, was examined at ages 1 year and 2
years 6 mo. Initially, his history was typical for PWS.
On examination at age 2 years 6 mos, he had continued
to be hypotonic. In addition, he had normal appetite,
poor weight gain, could not sit or walk alone, and spoke
only a few words. At the same age, temper tantrums, a
habit of picking sores, and thick viscous saliva were
present. His facial (fig. 2h) and general body appearance
resembled that of his sister. He also had hypogenitalism,
with small penis, hypoplastic scrotum, and cryptorchi-
dism, and was mildly mentally retarded. Height was 81
cm, and weight was 10 kg (both !3d percentile).
DNA Extraction, Southern Hybridization, and DNA
Methylation
DNA was extracted from blood leukocytes, for DNA-
methylation and microsatellite analyses, or from lym-
phoblast cell lines and was processed for Southern anal-
ysis by means of standard procedures (Driscoll et al.
1992; Mascari et al. 1992). The 32P-labeled probes, in-
cluding subclones of a phage contig spanning the IC and
the SNRPN gene and CpG island (probes E1–E3,
E3–E10, L48.3I, L48.6I, 0.6NE, c4.1, RN4RR, PW71B,
11H11R, and PAR-5), were prepared and used for
breakpoint, dosage, and DNA-methylation analyses, as
described elsewhere (Buiting et al. 1995; Dittrich et al.
1996; Glenn et al. 1996; Saitoh et al. 1996). The 393SS
probe was subcloned from phage B8 DNA (Glenn et al.
1996), by ScaI digestion and size selection on an agarose
gel of a 393-bp sequence upstream of SNRPN (GenBank
accession number U41384; Huq et al. 1997).
Microsatellite Analysis
PCR studies using 11 short tandem repeats and mi-
crosatellites from the 15q11-q14 region (D15S541,
D15S543, D15S11, D15S128, D15S10, D15S210,
D15S122, D15S113, D15S165, GABRB3, and
GABRA5) were performed for the family of PWS-B, by
use of standard protocols (Butler et al. 1996). Primers
for polymorphic marker studies were from the Genome
Database.
Reverse-Transcription (RT)–PCR Analysis of Gene
Expression
mRNAs were extracted from lymphoblastoid cell cul-
tures by use of either RNazol B (Biotecx) or the Quick-
Prep Micro mRNA purification kit (Pharmacia). Dupli-
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cate samples of 5–8 ml mRNA were treated with DNase
I, followed by cDNA synthesis using the Superscript-II
preamplification system (Gibco BRL) or the rTth RNA
PCR kit (Perkin-Elmer), in accordance with the sup-
plier’s protocols, with oligo dT as a primer for first-
strand cDNA synthesis and one aliquot with (RT) and
one without (RT) reverse transcriptase. Then, 4 ml of
the RT reaction was used for subsequent PCR amplifi-
cation of both RT and RT cDNAs in a total volume
of 25 ml containing 20 mM Tris-HCl (pH 8.4), 50 mM
KCl, 1.5 mM MgCl2, 200 mM each dNTP (dATP, dCTP,
dGTP, and TTP), 0.35 mM internal control primers (for
FBN), 0.7 mM specific primers, 2 U Taq polymerase
(Gibco BRL), by manual hot-start addition of the Taq
polymerase at 93C. The cycling conditions were 94C
for 2 min, followed by 35 cycles of 94C for 30 s, 56C
for 30 s, and 72C for 30 s, followed by 72C for 10
min. The PCR products were separated on a 1% agarose
gel in 0.5# Tris borate–EDTA buffer. Primers were as
described for IPW (Wevrick et al. 1994), SNRPN (RN85
and RN133, or E and L) (Sutcliffe et al. 1994; Glenn et
al. 1996), ZNF127 (DD29 and RN153) (Jong et al., in
press), PAR-1 and PAR-5 (Sutcliffe et al. 1994),GAPDH
(GenBank J04038), and fibrillin (FBN [GenBank
L13923]).
SSCP Analysis
In the families of three PWS patients (PWS-B, PWS-
29, and PWS-G) and seven controls (five normal, one
with an AS deletion, and one with a PWS deletion),
genomic DNA spanning the PWS shortest region of de-
letion overlap (SRO) was PCR amplified with 11 primer
sets, and the PCR products were digested with restriction
enzymes (RN528–RN429, BstNI/HincII or BstNI/
HaeIII; RN428–RN429, Sau3AI/HinfI; RN430–
RN431, BsaI/ApoI or HinfI; RN432–RN433, AvaII or
ScaI; RN434–RN435, uncut; RN434–RN437, AluI or
Sau3AI; RN436–RN437, HinfI or HincII; RN438–
RN439, Sau3AI or AluI; RN440–RN441, uncut;
RN495–RN496, AvaII/PvuII or MspI; and RN497–
RN498, AvaII orMspI) and analyzed by nonradioactive
SSCP. In brief, the DNA molecules were separated over-
night on mutation detection–enhancement gels (FMC
Bioproducts) and were visualized by silver staining, in
accordance with the manufacturer’s conditions. The
PCR products containing an abnormal bandwere cloned
into the pCR2.1 vector (Invitrogen) and were subjected
to DNA sequence analysis. The primer sequences, map,
and PCR conditions are available from the correspond-
ing author.
DNase I Hypersensitivity Studies
Lymphoblastoid cell lines derived from patients with
PWS or AS deletions were cultured in standard RPMI
medium supplemented with 10% FCS, penicillin, and
streptomycin (Life Technologies). Cells ( ) were8∼ 2# 10
harvested by centrifugation, washed in PBS, and quan-
titated with viability 195%, as judged by trypan blue
exclusion. The washed pellet was resuspended in lysis
buffer (60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 15
mM Tris [pH 7.4], 320 mM sucrose, 0.5 mM DTT, 0.2
mM AEBSF [a protease inhibitor; Calbiochem], and
0.5% NP–40), at cells/ml. The nuclei were7∼ 4# 10
washed with cold nuclear buffer (lysis buffer without
NP–40), to remove cytoplasmic debris and nucleases.
The washed nuclear pellets were resuspended in cold
nuclear buffer, at cells/ml, and immediately72.7# 10
were subjected to DNase I treatment.
DNase I (Life Technologies) was serially diluted in
chilled nuclear buffer (20–12,500 U/ml). Forty micro-
liters of each DNase I dilution, 360 ml of the nuclear
suspension, and 4 ml of 10 mM CaCl2 were combined
in a 15-ml polypropylene tube, mixed by inversion, and
incubated at 22C for 10 min. One nuclear aliquot was
combined with nuclear buffer and CaCl2 but without
DNase I, to control for potential endogenous nuclease
activity, and another aliquot was combined with nuclear
buffer only and then kept on ice, to provide an absolute
nuclease-free reference. After incubation, 400 ml stop
solution (20 mM EDTA, 1% SDS, and 1 mg proteinase
K/ml, at 55C) was added, mixed gently, and incubated
at 50C–55C overnight. The samples were extracted
with phenol/chloroform and chloroform and were pre-
cipitated with 2.5 M NH4OAc and 2.5 volumes of 95%
ethanol at room temperature. DNA precipitates were
collected by centrifugation, washed with 70% ethanol,
and dissolved in Tris-EDTA. BamHI restriction digests
were performed on one-half the recovered material (∼25
mg DNA), and the products were prepared for Southern
analysis by standard procedures.
Molecular Cloning and DNA Sequencing
Subclones and the DNA sequence for human SNRPN
are published (Glenn et al. 1996). Genomic bacterio-
phage l clones spanning Snrpn exons 1–3 were isolated
by use of mouse Snrpn exons 1–3 cDNA as probe (Ga-
briel et al. 1998). The DNA sequence was determined
from subclones across mouse exon 1 and the 5′ region,
by use of an ABI 377 automated DNA sequencer (Ap-
plied Biosystems).
Results
Previous analyses of microdeletions in three patients
with a PWS IM identified a 25-kb SRO that defines one
component of the IC (Buiting et al. 1995). The patients
with PWS in these families had the classic clinical phe-
notype (Saitoh et al. 1997). We therefore sought to iden-
402 Am. J. Hum. Genet. 64:397–413, 1999
Figure 3 DNAmethylation identifies PWS IMs. DNA was digested withXbaI/NotI, Southern blotted, and probed with the 0.6NE fragment
of the SNRPN 5′ CpG island. The upper 4.3-kb band represents the methylated allele, which is usually of maternal origin, and the lower 0.9-
kb band represents the unmethylated allele, which is of paternal origin. a, PWS-14. The SNRPN probe is deleted from the paternal allele (lane
1 is overloaded). b, PWS-B. Only the methylated band is present, but the patient is not deleted at this locus (lane 4), indicating that the paternal
chromosome has a maternal imprint. del  deletion, and N  normal.
tify smaller deletions of the IC in additional patientswith
PWS, to determine the molecular identity of the critical
IC elements.
Clinical Analysis of Patients with an IM
Ten patients with PWS, from seven families, were
identified for this study. Case reports are presented in
Subjects and Methods, and clinical photographs of key
patients are shown in figure 2. Two of these patients had
been reported previously (Mascari et al. 1992) as having
the classic PWS clinical phenotype (PWS-14; fig. 2a) or
an atypical phenotype (PWS-29; fig. 2b and c). In ret-
rospect, some of the apparently atypical features of PWS-
29, such as the less-typical facies, may be ascribed to
the clinical differences found in African American pa-
tients with PWS (Hudgins et al. 1998). Whereas one of
the affected PWS-T sibs had most of the clinical diag-
nostic features of PWS, his younger brother, at age 7
years, only had infantile hypotonia, language delay, and
above-average weight, without hyperphagia (Teshima
et al. 1996). Patients PWS-B (fig. 2d and e) and
PWS-G (fig. 2f) are nondeletion and had a typical PWS
phenotype.
Biparental Inheritance of 15q11-q13 Markers
The results of RFLP studies were reported previously
for PWS-14 and PWS-29 (Mascari et al. 1992), with
each patient having biparental inheritance for markers
within chromosome 15q11-q13. Likewise, use of mi-
crosatellite markers GABRB3, D15S11, D15S175,
D15S659, D15S1365, and 85CA for patient PWS-G,
GABRB3 for PWS-14, and D15S128 and D15S122 for
the two affected PWS-P sibs showed biparental inheri-
tance within 15q11-q13 for each patient (data not
shown).Microsatellite analysis of PWS-B showed similar
results, presented below. The PWS-T sibs showed a de-
letion at the SNRPN locus, by FISH, but not atD15S11,
D15S10, or GABRB3, although microsatellite analysis
of parental origin or extent was not performed (Teshima
et al. 1996). FISH studies for the PWS-J sibs indicated
an SNRPN deletion or a reduced signal but no deletion
for D15S11, D15S10, or GABRB3 (Ishikawa et al.
1996).
DNA Methylation within 15q11-q13
Probe 0.6NE from SNRPN exon 1 detects allele-spe-
cific DNA methylation (Sutcliffe et al. 1994; Buiting et
al. 1995; Glenn et al. 1996). As shown by the analyses
of patients with PWS and AS who have a 15q11-q13
deletion (fig. 3a, lanes 4 and 5; fig. 3b, lanes 2 and 3),
the maternal, methylated allele is detected by a 4.3-kb
band, and the paternal, unmethylated allele is detected
by a 0.9-kb band, byXbaI/NotI digestion. The probands
PWS-14 (fig. 3a, lane 1), PWS-B (fig. 3b, lane 4), PWS-
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29, and PWS-G and the PWS-T, PWS-J, and PWS-P af-
fected sibs (data not shown) lack the unmethylated 0.9-
kb band and have only the methylated 4.3-kb band,
which usually is of maternal origin only. A reduced band
intensity for patient PWS-14 and for the PWS-T, PWS-J,
and PWS-P affected sibs indicates that the SNRPN exon
1 region is deleted on the paternal allele. Consistent with
this interpretation, the DNA of the fathers of the PWS-
T and PWS-P affected sibs was deleted for this probe
and had only the 0.9-kb paternal, unmethylated band
(data not shown; DNA from the father in family PWS-
J was not available). Therefore, these two fathers have
inherited the deletion on the maternal chromosome, as
have similar cases (Buiting et al. 1995).
Because PWS-14 was deleted for the paternal SNRPN
exon 1 allele but the father had a normal methylation
pattern, the mutation appears to be a de novo event. All
other parents in these PWS families also had a normal
SNRPN methylation pattern. Furthermore, in probands
PWS-B, PWS-G, and PWS-29, the 4.3-kb band was of
double intensity, compared with normal for a single al-
lele (fig. 3b; data not shown). Therefore, these three pa-
tients have two copies of the SNRPN exon 1 region.
Since the methylation pattern was uniparental maternal,
the paternal chromosome has a maternal imprint.
The PWS-T (Teshima et al. 1996), PWS-J, and PWS-
P affected sibs and patients PWS-14, PWS-B, PWS-29,
and PWS-G were also tested for allelic methylation by
use of PW71B (Dittrich et al. 1993), as well as ZNF127
(DN34) for PWS-G (Driscoll et al. 1992). Each patient
showed a PWS pattern with only a methylated band, of
double intensity, except for the PWS-T sibs, who showed
a reduced signal (data not shown). In each case, the
parents showed normal biparental methylation patterns,
except for the father of family PWS-T, who showed a
maternal deletion of PW71 (Teshima et al. 1996). These
results indicate that the deletions in neither PWS-14 nor
the PWS-P sibs extend across the PW71B (D15S63)
locus, although the deletion in the PWS-T sibs does,
and confirm that DNA methylation throughout the im-
printed part of 15q11-q13 is abnormal.
Microdeletions of the IC
Microdeletions of the IC were detected in four of the
seven families with a PWS IM that were studied, in-
cluding all three families with two affected sibs.
Patient PWS-14.—For proband PWS-14, SNRPN ex-
ons 1–3 cDNA as probe (Glenn et al. 1996) detected
the telomeric breakpoint in EcoRI-digested DNA (fig.
4a). An abnormal 17.5-kb EcoRI band in PWS-14 was
detected in addition to the normal 14.5-kb exon 1 and
11-kb exon 2 bands, both of which were reduced to
50% intensity, whereas the exon 3 band was of normal
intensity and size (fig. 4a). In addition, an abnormal 26-
kb band and a normal 23-kb BamHI band, which were
reduced to 50% intensity, were present in the proband’s
DNA (data not shown). With this probe, no abnormal
band was detected in XbaI-digested DNA from PWS-
14, although the band for exons 2–3 was of normal
intensity, whereas the exon 1 band was of reduced in-
tensity (fig. 4c). A proximal probe (L48.3I) from the IC
region (Buiting et al. 1995) was intact and unrearranged
in PWS-14 (data not shown). Probe 393SS, located 8.1-
kb upstream of SNRPN exon 1 (fig. 4c), detected the
centromeric breakpoint in XbaI-digested DNA (6.6-kb
abnormal band) from proband PWS-14 (fig. 4b). The
breakpoint fragments were not detectable in the father
of PWS-14, by either Southern (fig. 4a and b) or PCR
(data not shown) analysis. Combined with the methyl-
ation data (see above), these results indicate that pro-
band PWS-14 has a paternally derived, de novo, 7.5-kb
microdeletion of the IC, with breakpoints located ∼3 kb
proximal and ∼4.5 kb distal to SNRPN exon 1 (fig. 4c).
Family PWS-J.—In DNA from the two affected sibs in
family PWS-J (Ishikawa et al. 1996), the c4.1 probe
(Buiting et al. 1997) and SNRPN exons 4–10 as probe
(E4–E10) (Glenn et al. 1996) detected an extra band for
both EcoRI and BamHI, but the PAR-5 probe (Sutcliffe
et al. 1994) detected an extra band only in EcoRI-di-
gested DNA and not in BamHI-digested DNA, defining
the telomeric breakpoint of a deletion (fig. 5). The in-
tensity of bands for probes 48.3I, 1.3XE, Y48.5, and
RN4RR (Buiting et al. 1995) was reduced to 50% of
normal, but the band for the PW71B probe was intact.
These results indicate that the distal breakpoint for the
PWS-J microdeletion is in the region of SNRPN exons
4–10, and the proximal breakpoint is between PW71B
and RN4RR (fig. 5).
Family PWS-P.—For family PWS-P, quantitative
Southern blot analysis with probe kb17 showed that
both sibs are deleted for the exon 1 region of SNRPN.
Further analysis showed that the deletion included IPW
and PAR-1 distally (data not shown). Upstream of
SNRPN, several probes (RN285/IC3, a PCR probe for
the AS SRO including exon IC3, and Y48.5) (Buiting et
al. 1995; Dittrich et al. 1996) showed 50% intensity,
compared with that of normal controls. Probe kb64, a
genomic clone that maps ∼1 kb distal to D15S128 and
spans exon IC2 of the IC transcript (Dittrich et al. 1996),
detected an abnormal fragment inBamHI-digestedDNA
and in KpnI-digested DNA of the patients and the father
(BamHI, normal band 20 kb and abnormal band 12 kb;
KpnI, normal band ∼25 kb and abnormal band 20 kb).
These results indicate that the deletion in PWS-P spans
1180 kb downstream of the SNRPN gene and that the
proximal breakpoint lies between IC2 (kb64) and Y48.5
(fig. 5).
Family PWS-T.—In family PWS-T (Teshima et al.
1996), the two affected sibs and the father had reduced
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Figure 4 Microdeletion of 7.5 kb in patient PWS-14. a,Distal breakpoint. SNRPN exons 1–3 cDNA as probe detected the distal breakpoint
in EcoRI-digested DNA. b, Proximal breakpoint. The 393SS probe detected the proximal breakpoint in XbaI-digested DNA. c, Map of the IC
microdeletion. The deletion is shown as a blackened bar. Arrows indicate breakpoint fragments. E  exon.
intensity of the bands for probes fromYAC end 11H11R
(Mutirangura et al. 1993) to PAR-1 (Sutcliffe et al. 1994)
(figs. 1 and 5), although FISH showed that the deletion
did not extend to D15S11, D15S10, orGABRB3 (Tesh-
ima et al. 1996). In addition, PW71 was deleted by
DNA-methylation analysis (Teshima et al. 1996), and
D15S13 (189-1) was shown to be intact by quantitative
Southern blot analysis (data not shown). Therefore, the
patients and the father have a relatively large deletion
(figs. 1 and 5).
The extent of all four new microdeletions and of the
three described elsewhere (Buiting et al. 1995) are sum-
marized in figure 5. The PWS-O distal breakpoint is
located ∼600 bp distal to SNRPN exon 1; therefore,
the PWS SRO has been reduced in this study, from ∼25
kb (Buiting et al. 1995) to 4.3 kb spanning exon 1 of
SNRPN (fig. 5).
Imprinted-Gene Expression within 15q11-q13
Analyses of imprinted-gene expression were per-
formed for the patient with the smallest microdeletion,
of only 7.5 kb (PWS-14; fig. 6a), and for one patient
with a PWS nondeletion IM (PWS-B; fig. 6b). Several
imprinted genes that are only paternally expressed were
studied, including the SNRPN, IPW, andZNF127 genes,
as well as the PAR-1 and PAR-5 expressed-sequence tags
(ESTs) (fig. 1). These studies showed that none of these
five genes or transcripts was expressed in the two pa-
tients with a PWS IM or in the controls with PWS de-
letions or UPD, whereas the control genes GAPDH and
FBN were expressed (fig. 6a and b). Likewise, SNRPN
was not expressed in blood or lymphoblast cells from
PWS-G (data not shown). All genes and transcripts were
expressed in cell lines from the mother of PWS-14, the
father of PWS-B, a normal control, and a control with
an AS deletion (fig. 6a and b).
DNase I Hypersensitivity of the SNRPN Gene and
the IC
We demonstrated above that the PWS component of
the IC spans 4.3 kb of exon 1 and the CpG island of
the SNRPN gene (fig. 5). Since the IC acts in cis, we
considered that the first exon of the SNRPN gene, which
encodes the translation start of an independent protein
Ohta et al.: Imprinting Mutations in Prader-Willi Syndrome 405
Figure 5 Summary map of PWS microdeletions, with SRO. The extent of each deletion is shown by a blackened bar, with new cases in
boldface (PWS-B, PWS-G, and PWS-29 are nondeleted); records for families PWS-O, PWS-U, and PWS-S and for the AS SRO are published
elsewhere (Buiting et al. 1995; Saitoh et al. 1996). A point mutation in family AS-C2 occurs in the splice donor site of an IC transcript (Dittrich
et al. 1996). The microdeletions in families with PWS or AS affect the maternal-to-paternal (“matrpat”) or the paternal-to-maternal (“patrmat”)
switch in the male or female germ line, respectively. Exons of the IC transcript and SNRPN (upper blackened boxes) and of the probes (lower
blackened boxes or horizontal lines [for L48.6I and L48.3I]) are shown.
(T. A. Gray, S. Saitoh, and R. D. Nicholls, unpublished
data), is an unlikely candidate for the IC element and
that the cis-acting IC factor most likely corresponds to
a DNA element within the 5′ part of the SNRPN gene.
To assess possible promoter function, we performed a
DNase I hypersensitive site (DHS) analysis of the
SNRPN 5′ region, since sites exhibiting a high degree of
DNase I hypersensitivity generally represent binding
sites for DNA sequence–specific binding factors (Gross
and Garrard 1988).
Two cell lines were used to assess the DNase I acces-
sibility of the chromatin at the 5′ end of SNRPN and to
discern any parent-of-origin specificity. These lines were
derived from patients with PWS (PWS-109) or AS (AS-
139) who have a 4-Mb deletion of paternal or maternal
origin and in whom the remaining allele, therefore,
has been maternally or paternally derived, respectively.
Chromatin exposed to DNase I will be cleaved, and the
position of the site of cleavage can be estimated by mea-
surement of the length of the generated fragment relative
to a landmark restriction site. DNA from DNase I–
treated nuclei was cut with BamHI, Southern blotted,
and probed with a 2.2-kb EcoRI/BamHI fragment in the
first intron of SNRPN (Glenn et al. 1996). A major DHS
∼3.1 kb from the BamHI intronic site was identified only
in the AS-139 cell line (fig. 7). This maps the exposed
chromatin to a region spanning ∼100–300 bp upstream
of the SNRPN transcription start site. The maternally
inherited SNRPN 5′ region in PWS-109 was devoid of
DHS, indicating a closed, inaccessible chromatin con-
formation. The major DHS was verified in a second ex-
periment using EcoRI-digested DNA and a probe in-
cluding exon 1 and 500 bp of SNRPN intron 1 (data
not shown). A second paternal-specific DHS was iden-
tified within intron 1, but it appeared as a dispersed
signal (fig. 7), since it lies within the region spanned by
the probe, and is best detected with other restriction
digests and probes (C. C. Glenn, R. D. Nicholls, and T.
P. Yang, unpublished data). These findings unequivocally
demonstrate that the SNRPN chromatin is in an open
configuration exclusively on the paternally derived allele.
The paternal-specific DHS identified here and results
from standard transfection assays (Huq et al. 1997) are
consistent with this region corresponding to a functional
promoter of the SNRPN gene.
Evolutionary Footprints in the IC
To further define genetic elements within the 4.3-kb
PWS SRO, we performed a phylogenetic analysis of hu-
man SNRPN and mouse Snrpn exon 1 and the 5′ pu-
tative promoter regions. A phylogenetic footprint is de-
fined by at least six contiguous bases of absolute
conservation in orthologous genes of evolutionarily dis-
tant species (Gumucio et al. 1992). Our sequence com-
parison identified six phylogenetic footprints of 7–10
nucleotides in the human SNRPN and mouse Snrpn pro-
moter regions, corresponding to the 4.3-kb human PWS
SRO in the IC (fig. 8). There was also a 10-bp block of
T4A6, but previous studies of the g-globin gene promoter
have shown that no specific trans-acting factors bind
simple-sequence tracts of this nature (Gumucio et al.
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Figure 6 Silencing of paternal-only gene expression in PWS IMs. Paternally expressed genes and transcripts across a 1.0–1.5-Mb domain
(ZNF127, SNRPN, PAR-5, IPW, and PAR-1) are not expressed in (a) PWS-14, a patient with PWS who has a 7.5-kb microdeletion, or in (b)
PWS-B, a patient with PWS who does not have an IC mutation. RT-PCR expression analysis of lymphoblast cell lines of the patients and
controls are shown. RT-PCR analysis of the control GAPDH (a) and FBN (b) genes shows expression in all the RT samples.
1992). Since these are the only conserved nucleotides in
the 4.3-kb PWS-SRO region, these sites represent can-
didate binding elements for the factor(s) involved in so-
matic expression and/or the maternal-to-paternal im-
print switch in the male germ line.
Patients with a PWS Nondeletion IM
Three patients with an IM (PWS-B, PWS-G, and PWS-
29) did not show a microdeletion in a 150-kb IC region
flanking the promoter of the SNRPN gene (fig. 5), on
extensive analysis. For the family of PWS-B, the pro-
band, two unaffected sibs, the parents, and the paternal
grandparents were typed by DNAmicrosatellitemarkers
within 15q11-q14 (fig. 9). The younger brother, who is
unaffected, has the same nonrecombinant paternal hap-
lotype as the proband (fig. 9). This result indicates either
a de novo mutation or the lack of a chromosome 15q11-
q13 mutation. It should be noted that the paternal hap-
lotype for PWS-B was inherited from the paternal grand-
mother (fig. 9).
Mutation analysis was performed for the three pa-
tients with nondeletions, by use of 11 PCR primer sets
across the 4.3-kb PWS SRO. To be a mutation-causing
PWS, a sequence change must either occur de novo or
be paternally inherited. No mutations were found in
these patients, although three polymorphisms were de-
tected (table 1). For example, SSCP analysis of DNA
from the family of PWS-B identified a paternally inher-
ited sequence change, by use of AvaII/PvuII-digested
PCR product from primers RN495 and RN496, and
DNA sequence analysis identified a single-nucleotide
change (GrC) at position 64 of the SNRPN promoter
region (table 1 and fig. 8). This sequence change was
classified as a polymorphism, since a normal sib has the
same paternally inherited and nonrecombinant haplo-
type as PWS-B (fig. 9). A maternally inherited—and,
hence, polymorphic—sequence change was identified in
the 4.3-kb PWS SRO in patient PWS-29 DNA as a sin-
gle-base change (GrT) at position 94 in SNRPN in-
tron 1 (table 1). An ArG change at position 64 in
SNRPN intron 1 in PWS-G DNA (table 1), which had
not been maternally inherited (the father and unaffected
sibs were not available for study), was classified as a
polymorphism, because it is not evolutionarily conserved
in mouse DNA, as was also found for the other two
polymorphisms (fig. 8).
Discussion
In this study, we performed molecular genetic studies
of seven families, involving 10 patients with PWS and
a mutation in the imprinting process, to better define
the sequence elements that play a role in the maternal-
to-paternal imprint switch in the male germ line. We
identified two subclasses of patients with a PWS IM,
deletion and nondeletion. Previously, microdeletions had
been characterized completely in only three cases of PWS
(Buiting et al. 1995), defining a 25-kb PWS SRO. Two
additional cases were identified by FISH and molecular
analyses, but deletion extents were not determined (Sut-
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Figure 7 A paternal-specific DHS in the PWS SRO. a, Nuclei from lymphoblastoid cell lines with a maternally derived (AS-139) or
paternally derived (PWS-109) 15q11-q13 deletion were treated with varying concentrations of DNase I. The resulting genomic DNAs were cut
withBamHI (“B”), Southern blotted, and probedwith anEcoRI (“E”)/BamHI fragment from intron 1 of SNRPN. In AS-139, amajor subfragment
was generated in nuclei exposed to 50 and 250 U DNase I/ml, indicating the presence of a DHS ∼3.1 kb upstream of the distal BamHI site.
No specific DHSs were seen in PWS-109. b, Schematic diagram depicting the relative positions of the PWS SRO (blackened bar), the probe
fragment (hatched bar), the SNRPN exon 1 transcription start (thin arrow), and the major DHS (thick arrow).
cliffe et al. 1994; Butler et al. 1996). Our new analyses
have identified, in one patient with PWS, a very small
deletion of only 7.5 kb that narrows the critical region
for the IC element involved in the male germ-line switch
to only 4.3 kb (the PWS SRO). This region represents
the promoter for the SNRPN gene, implying that this
one gene plays a critical role in the germ-line cis regu-
lation of all imprinted genes over a 1.5–2-Mb domain
within 15q11-q13.
Epigenetic Effects of PWS IMs
Microdeletion.—Four of these IM cases (in families
PWS-T, PWS-P, and PWS-J and patient PWS-14) dem-
onstrated a microdeletion. For the first two cases, the
PWS patients inherited an IM from their father, who had
inherited the mutation from his mother. These familial
inheritance patterns are consistent with our previous
model, in which a mutation in the PWS-SRO component
of the IC in the germ line of an ancestral female would
lead to fixation of the maternal imprint in that chro-
mosome (Buiting et al. 1995). In PWS-14, the IC mu-
tation was de novo on the paternally inherited chro-
mosome, but the grandparental origin of this mutation
and of that in PWS-J should be grandmaternal, since a
maternal epigenotype was fixed. Since the mutated chro-
mosome exhibits a normal maternal imprint, it can
transmit silently through females. However, it is blocked
from switching to a paternal imprint in the germ line of
a male, and such males have a 50% risk of having a
child who inherits only maternally imprinted chromo-
somes 15, leading to PWS.
The abnormal imprint, or epigenotype, in such cases
of PWS includes all normal paternally expressed genes
in the 1.5–2-Mb imprinted domain, from ZNF127
through IPW (fig. 1), based on the loss of paternal-only
gene expression in PWS microdeletions ranging in size
from 7.5 kb (PWS-14) to larger PWS deletion IMs (Sai-
toh et al. 1996). DNA-methylation changes in cases of
deletions and nondeletions are also consistent with this
conclusion. Since all paternal-only gene expression in
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Figure 8 Phylogenetic footprints within the PWS SRO. The transcription start site for human SNRPN and mouse Snrpn genes are indicated
by arrows, and mouse and human promoter sequences are aligned 5′ of these start sites (determined by use of the Clustal algorithm, with
modifications to maximize parsimony). Six putative evolutionarily conserved footprints, which are likely to represent TF binding sites, are
identified (blackened boxes [top] and boxed sequences [bottom]). One or more of these TF binding sites are also candidates for the IC imprint-
switch element.
15q11-q13 is lost, these results clearly explain why pa-
tients with a PWS IM have the classic phenotype for the
disorder (Saitoh et al. 1997; this study). These conclu-
sions have been confirmed by an equivalent deletion in
a mouse model of a PWS IM, with loss of paternal gene
expression over several megabases (Yang et al. 1998),
as in humans.
Nondeletion.—Several sporadic cases (PWS-B, PWS-
29, and PWS-G) had neither a detectable deletion of the
IC region nor a mutation in the PWS SRO. Similar find-
ings were recently found for approximately one-half the
patients with a PWS or AS IM (Bu¨rger et al. 1997; Buit-
ing et al. 1998). As with deletion cases, patients with
PWS nondeletions have not switched the imprint
throughout the imprinted 2-Mb domain in 15q11-q13,
as was demonstrated here for PWS-B, a patient with a
nondeletion, by gene-expression and DNA-methylation
studies. Therefore, we consider a prefertilization im-
print-switch failure to be most likely, since the IC has
not been shown to have a function in somatic cells, al-
though a postzygotic event cannot be excluded (Bu¨rger
et al. 1997; Buiting et al. 1998). In one family (that of
PWS-B), a normal sib shares the same paternal haplotype
as the patient, which is similar to that in two other
families (Buiting et al. 1998) and indicates either a de
novo mutation in the father’s germ line or the lack of a
mutation in 15q11-q13. Whereas a mutation in a gene
encoding a trans-acting factor could occur, this might
be expected to affect all germ cells and, hence, all off-
spring, which is inconsistent with our observations, un-
less each such mutation was de novo (the effect also
would have to be specific for 15q11-q13). Since all pa-
tients with a PWS or AS nondeletion IM are sporadic
(Bu¨rger et al. 1997; Buiting et al. 1998; this report), we
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Figure 9 Microsatellite haplotype analysis of the family of PWS-
B. Haplotypes were generated by use of the marker loci shown. One
normal sib has the same paternal haplotype (boxed) as patient PWS-
B, and this haplotype was derived from the paternal grandmother.
Table 1
PWS-SRO Polymorphisms in Patients with a PWS Nondeletion IM
FAMILY
NUCLEOTIDE
POSITIONaPatient Mother Father
PWS-B GrC G GrC 64
PWS-G ArG A ) 64
PWS-29 GrT GrT G 94
NOTE.—Changes in sequence from the cloned SNRPN locus (Glenn
et al. 1996) are indicated by use of an arrow.
a Relative to the SNRPN transcription-initiation site at 1.
favor the former hypothesis—namely, that there is no
mutation, with a developmental or stochastic failure to
switch the imprint in the male or female germ line, re-
spectively. Developmental delay can lead to defects in
sex determination (Mittwoch 1992), and germ-cell delay
can occur as a consequence of skewed X inactivation
(Lau et al. 1997). Whereas this hypothesis may be dif-
ficult to prove, since neither the parent nor the child
actually has a mutation, animal models may provide
support for these ideas.
SNRPN Promoter Contains the IC Critical Elements for
Imprint Switching in Males
All seven PWS microdeletions fully characterized here
and previously (Buiting et al. 1995) overlap and narrow
the PWS SRO of the IC, to 4.3 kb (fig. 5). There are
two high-copy Alu repeat sequences at the proximal
(centromeric) end of the PWS SRO, reducing to only 3.7
kb the amount of unique sequence in the PWS SRO.
Indeed, the distance from the distal point of the PWS
SRO (just inside SNRPN intron 1) to the first 5′ Alu is
only 2.03 kb; therefore, the latter segment is most likely
to contain the IC critical element(s).
The critical PWS-SRO region corresponds to the
SNRPN transcription promoter, on the basis of four lines
of evidence. First, this region contains the SNRPN tran-
scription start site in a 5′ differentially methylated CpG
island (Sutcliffe et al. 1994; Glenn et al. 1996). Second,
our DNase I hypersensitivity studies indicated paternal-
specific open chromatin in this region, which is typical
of binding sites for DNA sequence–specific transcription
factors (TFs) (Gross and Garrard 1988). This correlates
with the paternal-only transcription of SNRPN. Prelim-
inary studies of the remaining 120 kb of the IC failed
to identify similar sites, at least in lymphoblastoid cell
lines. Third, our phylogenetic footprint analyses of the
PWS SRO from human SNRPN and the equivalent re-
gion of mouse Snrpn identified six conserved elements,
which are likely to be recognition sites for positive or
negative TFs involved in somatic cell gene expression of
SNRPN. Since SNRPN expression is upregulated in the
postnatal brain (Schmauss et al. 1992; Grimaldi et al.
1993), there may be both silencing elements in nonex-
pressing tissues and activating elements in expressing
tissues. Furthermore, one or more of these conserved-
sequence elements may also be involved in the imprint-
switch process. Finally, transfection studies of fragments
from the proximal part of the SNRPN 5′ region (207
to 53 bp) have established this region as having pro-
moter function (Huq et al. 1997). However, the latter
studies (Huq et al. 1997) likely define only a “minimal”
promoter, since the constructs used lack two phyloge-
netically conserved elements (408 and 474 bp, rel-
ative to SNRPN; fig. 8) upstream of the transcription
start site.
Therefore, the SNRPN promoter appears to contain
the critical IC elements for the imprint switch during
spermatogenesis. The imprint switch may involve a two-
step process of initial erasure of all previous imprints,
followed by an active resetting, or a single switch
wherein a parental imprint is imposed specific for the
sex of that individual. The IC represents the first step in
imprint switching, since all known imprinted genes
within 15q11-q13 and mouse models do not switch their
gametic and somatic methylation or expression patterns
unless the IC signal is received (Glenn et al. 1996; Saitoh
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et al. 1996; Nicholls et al. 1998; Yang et al. 1998; Jong
et al., in press; this study). Therefore, the IC signal must
be bidirectionally transmitted to each imprinted gene
within 15q11-q13 (fig. 1), which then switches its own
imprint. At present, we can only recognize mutations in
PWS and AS in the first step of the imprint-switch pro-
cess. It will be important in future work to identify mu-
tations in each step of the imprint-switch process during
gametogenesis, by means of patient analyses or, more
likely, by involving targeted mutagenesis and transgene-
sis in the mouse.
Models for Imprint Switching during Spermatogenesis
On the basis of our findings, non–mutually exclusive
models for imprint switching during gametogenesis can
be proposed. In the first model, imprint switching in
female and male germ cells may involve a form of pro-
moter or enhancer competition. Expression in the oocyte
of a novel, noncoding, paternal-only IC transcript may
preclude transcription from the SNRPN promoter, al-
lowing silencing to be established at the latter site (Dit-
trich et al. 1996; Buiting et al. 1998; Lyko et al. 1998;
Nicholls et al. 1998). This may be accomplished because
the IC transcript splices to SNRPN exon 2 (Dittrich et
al. 1996), and, consistent with this role, it was mutated
in all patients with an AS IM who were examined (Buit-
ing et al. 1995; Dittrich et al. 1996; Saitoh et al. 1996;
C. Farber, B. Dittrich, K. Buiting, and B. Horsthemke,
unpublished data). Silencing then may spread, from the
5′ end of the SNRPN gene, throughout 15q11-q13 by
an unknown mechanism, although this could involve
chromatin factors involved in silencing in other organ-
isms (Paro and Harte 1996), which would establish the
maternal imprint characteristic of the oocyte and would
complete the switch from a previous paternal imprint.
In contrast, an active SNRPN promoter would prevent
expression of the IC transcript during spermatogenesis.
Therefore, the IC transcript would not be required for
paternal imprinting in spermatogenesis, and IC muta-
tions would have no effect upon paternal transmission,
as was observed in families with an AS IM.
The above model assumes a role for a silencing mech-
anism in the imprint-switch process. By use of Dro-
sophila as a model system in vivo, fragments from the
5′ regulatory region of SNRPN have been demonstrated
to function as a silencer in transgenic flies and have been
interpreted to indicate that the imprinting mechanism
may involve evolutionarily conserved components (Lyko
et al. 1998). Whereas the observed silencing in somatic
cells of transgenic flies was bidirectional and occurred
over distances of only several kilobases, it was parent-
of-origin independent (Lyko et al. 1998). Further-
more, SNRPN expression is predominantly in neurons
(Schmauss et al. 1992; Grimaldi et al. 1993; Glenn et
al. 1996), and it is well known that many neuronal-
specific genes have silencer elements within the gene pro-
moter that silence gene expression in nonneural tissues
(for a review, see Schoenherr and Anderson 1995).
Therefore, it is quite likely that the SNRPN gene has
promoter silencer elements that extinguish high levels of
expression in nonneural tissues, and such a silencer el-
ement that is active in somatic cells could provide an
alternative explanation for the Drosophila results ob-
tained by Lyko et al. (1998).
An enhancer-competition model was first described
for the b-globin locus control region (LCR), in which
differential transcription of the five b-like globin genes
during erythroid development is controlled by promoter
competition of each of these genes, for interaction with
the LCR enhancer components (Choi and Engel 1988;
Crossley and Orkin 1993; Dillon et al. 1997). An en-
hancer-competition model may also explain the differ-
ential imprinting of the maternally expressed H19 and
paternally expressed Igf2 genes in somatic cells (Barto-
lomei et al. 1993; Leighton et al. 1995). A similar en-
hancer-competition model, involving a shared neuronal-
specific enhancer, was recently proposed as a basis for
IMs in PWS and AS (Tilghman et al. 1998). Neverthe-
less, this hypothesis is unlikely, since (1) the PWS and
AS genes are unlikely to be expressed in the same cell
type, as required by this hypothesis; (2) the AS SRO is
not a maternal epigenetic mark (Schumacher et al.
1998); and (3) the imprint switch occurs in germ cells,
not postfertilization (Dittrich et al. 1996; Saitoh et al.
1996; Nicholls et al. 1998; this study). Antisense gene
regulation is an alternative form of transcription com-
petition that could play a role in imprint switching, since
it is used in transcription control by several imprinted
genes (Wutz et al. 1997; Rougeulle et al. 1998; Jong et
al., in press).
In an alternative model, during spermatogenesis the
binding of a TF(s) to one or more of the conserved bind-
ing sites on the methylated, maternally derived SNRPN
allele may allow direct activation of transcription of the
SNRPN gene, which represents the paternal imprint. TFs
that can bind unmethylated and methylated DNA are
known—for example, Sp1 (Harrington et al. 1988)—al-
though none of the sites on the SNPRN promoter appear
to represent Sp1-recognition motifs. Alternatively, the
TF may serve to prevent silencing, by displacement of
the silencing proteins. In either model, concomitant
changes in DNA methylation must occur in the SNRPN
gene, to establish the gametic methylation pattern (pa-
ternal loss of methylation at the 5′ end and methylation
at the 3′ end of the gene) (Glenn et al. 1996; Shemer et
al. 1997), by an unknown mechanism. These events are
then followed by bidirectional spreading of the IC signal
to each imprinted gene in 15q11-q13.
We currently are using oligonucleotides containing
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each of the phylogenetically conserved motifs in the
SNRPN promoter to identify TFs, from various cell
types, that may bind to these sites. Identification of pa-
tients with a PWS IM who have smaller deletions or
targeted mutagenesis in mice would also further define
which of these putative TF binding sites are involved in
the maternal-to-paternal imprint switch during sper-
matogenesis. This IC-switch element is mutated in pa-
tients with PWS, but it has no role during oogenesis,
since, in families with PWS, mutations of this element
transmit silently through female ancestors (Buiting et
al. 1995; this study). Silent maternal transmission of
SNRPN mutations is also consistent with the transcrip-
tion inactivity of this gene from the maternal chromo-
some. In addition to a cis role for the SNRPN promoter
during spermatogenesis, it is possible that the SNRPN
transcription unit may play a role in the clinical features
of PWS, since AS IM microdeletions have not spanned
closer than 20 kb from the 5′ end of SNRPN (Buiting
et al. 1995; Ohta et al. 1999). These AS mutations
transmit silently through male ancestors, but, if a de-
letion extended into promoter or enhancer elements of
SNRPN, such individuals may show PWS features, in-
cluding hypogonadism and sterility.
In conclusion, our studies of PWS and AS IMs have
identified a novel mechanism of human disease, in which
the mutation blocks the switch of the grandparental im-
print in the parental germ line and which is the conse-
quence of inheritance of an incorrect parental imprint
that leads to the clinical manifestations in offspring.
Nevertheless, these PWS and AS IMs identify only the
first step of imprint switching in the germ line. To fully
understand the molecular basis of imprint switching in
the germ line, it will be necessary to identify mutations,
in patients or mouse models, that block successive stages
of imprint switching at the IC, bidirectional spreading
of the IC signal, recognition by each imprinted “target”
gene, and switching of the gametic methylation patterns
by each target gene. A detailed understanding of the
molecular basis and consequences of mutations in the
imprinting process, in PWS and AS, may also lead to
insight into similar IMs or “loss of imprinting” in Beck-
with-Wiedemann syndrome (Reik andMaher 1997) and
in many childhood and adult cancers (Feinberg et al.
1994).
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